{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:28Z","timestamp":1792036288231,"version":"4.4.0"},"reference-count":55,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/100010119","name":"Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkl\u00e9ns Minne","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100010119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007639","name":"Maire Taposen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100007639","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HUS","award":["Y223525023"],"award-info":[{"award-number":["Y223525023"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Risk and outcome of cancer for patients with multiple sclerosis (pwMS) remain disputed. We aimed to investigate cancer incidence and cancer-specific mortality rates in pwMS compared with a matched population sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this nationwide retrospective population-based study, pwMS in Finland were identified from the National MS-registry and the Care Register for Healthcare and matched to up to five population controls with data from 1974 until 2021. Standardised incidence rates, relative risks and HRs were calculated for all cancers and cancer subtypes utilising the Finnish Cancer Registry. A standardised mortality ratio (SMR) for cancer-specific causes was calculated, and survival analysis using a cumulative incidence function with a competing risk model of the probability of death was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found 16\u2009815\u2009MS patients and selected 80\u2009950 controls. Follow-up time was a median of 15.2 (8.2\u201322.9) years for pwMS and 17.5 (9.5\u201326.0) years for controls. Mean age at the diagnosis of first cancer was lower in pwMS (61.4y; SD 11.89) compared with controls (64.5y; 12.53; p&lt;0.001). PwMS had a similar risk for all cancers (SIR 0.96; 95%\u2009CI 0.90 to 1.03) compared with controls. For males, the risk was lower (SIR 0.83; 95%\u2009CI 0.72 to 0.94). SMR showed that cancer-specific mortality for all cancers was similar to controls (1.02; 95%\u2009CI 0.93 to 1.11).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with MS have a similar risk for cancer and equal cancer-specific mortality compared with population controls. However, pwMS are diagnosed with cancer at a younger age compared with controls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-338301","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:21:20Z","timestamp":1782926480000},"page":"851-858","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-0554","authenticated-orcid":false,"given":"Anna","family":"Maunula","sequence":"first","affiliation":[{"name":"Translational Immunology Research Program, University of Helsinki, Helsinki, Finland"},{"name":"Department of Neurology, Hyvink\u00e4\u00e4 Hospital, HUS Neurokeskus, Hyvink\u00e4\u00e4, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini M","family":"Laakso","sequence":"additional","affiliation":[{"name":"Translational Immunology Research Program, University of Helsinki, Helsinki, Finland"},{"name":"HUS Neurokeskus, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-2410","authenticated-orcid":false,"given":"Matias","family":"Viitala","sequence":"additional","affiliation":[{"name":"Aastat Ltd, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-0483","authenticated-orcid":false,"given":"Marja-Liisa","family":"Sumelahti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Pirkanmaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-9325","authenticated-orcid":false,"given":"Sari","family":"Atula","sequence":"additional","affiliation":[{"name":"HUS Neurokeskus, Helsinki, Uusimaa, Finland"},{"name":"Clinical Neurosciences, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026091402101028000_97.10.851.1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ane.13057","article-title":"Multiple sclerosis epidemiology in Finland: Regional differences and high incidence","volume":"139","author":"Pirttisalo","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"2026091402101028000_97.10.851.2","article-title":"Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up","volume":"2014","author":"Sumelahti","year":"2014","journal-title":"Mult Scler Int"},{"key":"2026091402101028000_97.10.851.3","article-title":"Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria-a nationwide population-based registry study over five decades","volume":"11","author":"Maunula","year":"2025","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"2026091402101028000_97.10.851.4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.amjmed.2017.11.044","article-title":"Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts","volume":"131","author":"Zurawski","year":"2018","journal-title":"Am J Med"},{"key":"2026091402101028000_97.10.851.5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510379244"},{"key":"2026091402101028000_97.10.851.6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh104"},{"key":"2026091402101028000_97.10.851.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03668.x"},{"key":"2026091402101028000_97.10.851.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-315238"},{"key":"2026091402101028000_97.10.851.9","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16480","article-title":"Stable excess mortality in a multiple sclerosis cohort diagnosed 1970-2010","volume":"31","author":"Sumelahti","year":"2024","journal-title":"Eur J Neurol"},{"key":"2026091402101028000_97.10.851.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188120","article-title":"Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study","volume":"12","author":"Moisset","year":"2017","journal-title":"PLoS ONE"},{"key":"2026091402101028000_97.10.851.11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345366.10455.62"},{"key":"2026091402101028000_97.10.851.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws148"},{"key":"2026091402101028000_97.10.851.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5929-9"},{"key":"2026091402101028000_97.10.851.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-2229-4"},{"key":"2026091402101028000_97.10.851.15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2016.09.005","article-title":"Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk","volume":"370","author":"Gaindh","year":"2016","journal-title":"J Neurol Sci"},{"key":"2026091402101028000_97.10.851.16","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507083625"},{"key":"2026091402101028000_97.10.851.17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.msard.2019.08.005","article-title":"Risk of cancer among Finnish multiple sclerosis patients","volume":"35","author":"Hongell","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"2026091402101028000_97.10.851.18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00415-020-10170-5","article-title":"Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study","volume":"268","author":"Zecca","year":"2021","journal-title":"J Neurol"},{"key":"2026091402101028000_97.10.851.19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00337","article-title":"Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort","volume":"10","author":"D\u2019Amico","year":"2019","journal-title":"Front Neurol"},{"key":"2026091402101028000_97.10.851.20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2018.12.014","article-title":"Multiple sclerosis and cancer incidence: A Danish nationwide cohort study","volume":"28","author":"N\u00f8rgaard","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"2026091402101028000_97.10.851.21","doi-asserted-by":"publisher","DOI":"10.1159\/000079947"},{"key":"2026091402101028000_97.10.851.22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21437"},{"key":"2026091402101028000_97.10.851.23","doi-asserted-by":"crossref","first-page":"105091","DOI":"10.1016\/j.msard.2023.105091","article-title":"Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study","volume":"80","author":"Greenfield","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2026091402101028000_97.10.851.24","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1177\/1352458519877244","article-title":"Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study","volume":"26","author":"Grytten","year":"2020","journal-title":"Mult Scler"},{"key":"2026091402101028000_97.10.851.25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/ene.15226","article-title":"Incidence and risk of cancer among multiple sclerosis patients: A matched population-based cohort study","volume":"29","author":"Bosco-L\u00e9vy","year":"2022","journal-title":"Eur J Neurol"},{"key":"2026091402101028000_97.10.851.26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jocn.2022.06.025","article-title":"Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort: A population-based cohort study in the Netherlands using the PHARMO Database Network","volume":"103","author":"Kuiper","year":"2022","journal-title":"Journal of Clinical Neuroscience"},{"key":"2026091402101028000_97.10.851.27","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209885","article-title":"Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study","volume":"103","author":"Pierret","year":"2024","journal-title":"Neurology"},{"key":"2026091402101028000_97.10.851.28","doi-asserted-by":"crossref","first-page":"102650","DOI":"10.1016\/j.autrev.2020.102650","article-title":"Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis","volume":"19","author":"Ghajarzadeh","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026091402101028000_97.10.851.29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011219"},{"key":"2026091402101028000_97.10.851.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165027","article-title":"Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients","volume":"11","author":"Hajiebrahimi","year":"2016","journal-title":"PLoS One"},{"key":"2026091402101028000_97.10.851.31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","article-title":"Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours","volume":"77","author":"Leinonen","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026091402101028000_97.10.851.32","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000227","article-title":"Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma","volume":"3","author":"Montgomery","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026091402101028000_97.10.851.33","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512449682"},{"key":"2026091402101028000_97.10.851.34","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-322941"},{"key":"2026091402101028000_97.10.851.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02031.x"},{"key":"2026091402101028000_97.10.851.36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/ene.12710","article-title":"All-cause mortality following a cancer diagnosis amongst multiple sclerosis patients: a Swedish population-based cohort study","volume":"22","author":"Roshanisefat","year":"2015","journal-title":"Eur J Neurol"},{"key":"2026091402101028000_97.10.851.37","doi-asserted-by":"crossref","first-page":"104417","DOI":"10.1016\/j.msard.2022.104417","article-title":"Cancer related mortality in multiple sclerosis. A population based cohort study","volume":"69","author":"Grytten","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2026091402101028000_97.10.851.38","first-page":"e13","article-title":"Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study","volume":"97","author":"Marrie","year":"2021","journal-title":"Neurology"},{"key":"2026091402101028000_97.10.851.39","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508093890"},{"key":"2026091402101028000_97.10.851.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.07.008"},{"key":"2026091402101028000_97.10.851.41","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13145"},{"key":"2026091402101028000_97.10.851.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103209"},{"key":"2026091402101028000_97.10.851.43","first-page":"e1447","article-title":"Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study","volume":"97","author":"Marrie","year":"2021","journal-title":"Neurology"},{"key":"2026091402101028000_97.10.851.44","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211056692"},{"key":"2026091402101028000_97.10.851.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.07.020"},{"key":"2026091402101028000_97.10.851.46","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512436596"},{"key":"2026091402101028000_97.10.851.47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122686","article-title":"Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS ONE"},{"key":"2026091402101028000_97.10.851.48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00415-023-11980-z","article-title":"Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies","volume":"271","author":"Li","year":"2024","journal-title":"J Neurol"},{"key":"2026091402101028000_97.10.851.49","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt281"},{"key":"2026091402101028000_97.10.851.50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001736","article-title":"Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury","volume":"94","author":"Ho","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026091402101028000_97.10.851.51","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.601"},{"key":"2026091402101028000_97.10.851.52","unstructured":"Sy\u00f6p\u00e4rekisteri . Sy\u00f6p\u00e4tilastosovellus. Available: https:\/\/syoparekisteri.fi\/tilastot\/tautitilastot\/ [Accessed 26 Feb 2025]."},{"key":"2026091402101028000_97.10.851.53","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13112-1","article-title":"Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study","volume":"272","author":"Kuutti","year":"2025","journal-title":"J Neurol"},{"key":"2026091402101028000_97.10.851.54","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-1930-2"},{"key":"2026091402101028000_97.10.851.55","doi-asserted-by":"publisher","DOI":"10.1177\/1403494812456637"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-338301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:10:38Z","timestamp":1789377038000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-338301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,14]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jnnp-2025-338301"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-338301","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}